Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate
© 2022 Elsevier B.V. All rights reserved.
| Publié dans: | Biochemical engineering journal. - 1998. - 181(2022) vom: 12. Apr., Seite 108403 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , |
| Format: | Article en ligne |
| Langue: | English |
| Publié: |
2022
|
| Accès à la collection: | Biochemical engineering journal |
| Sujets: | Journal Article Biologics manufacturing Broad spectrum antiviral COVID-19 Downstream recovery Griffithsin |
| Accès en ligne |
Volltext |